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Background: Asymmetric NG,NG-dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is
regulated by the enzymatic participants of synthetic and metabolic processes, i.e., type I protein N-arginine
methyltransferase (PRMT) and dimethylarginine dimethylaminohydrolase (DDAH). Previous reports have
demonstrated that circulating ADMA levels can vary in patients with type 1 and type 2 diabetes mellitus (T2DM).
White adipose tissue expresses the full enzymatic machinery necessary for ADMA production and metabolism;
however, modulation of the activities of adipose ADMA-related enzymes in T2DM remains to be determined.
Methods: A rodent model of T2DM using 11- and 20-week old Goto-Kakizaki (GK) rats was used. The expression
and catalytic activity of PRMT1 and DDAH1 and 2 in the white adipose tissues (periepididymal, visceral and
subcutaneous fats) and femur skeletal muscle tissue were determined by immunoblotting, in vitro methyltransferase
and in vitro citrulline assays.
Results: Non-obese diabetic GK rats showed low expression and activity of adipose PRMT1 compared to age-matched
Wistar controls. Adipose tissues from the periepididymal, visceral and subcutaneous fats of GK rats had high DDAH1
expression and total DDAH activity, whereas the DDAH2 expression was lowered below the control value. This dynamic
of ADMA-related enzymes in white adipose tissues was distinct from that of skeletal muscle tissue. GK rats had lower
levels of serum non-esterified fatty acids (NEFA) and triglycerides (TG) than the control rats. In all subjects the adipose
PRMT1 and DDAH activities were statistically correlated with the levels of serum NEFA and TG.
Conclusion: Activities of PRMT1 and DDAH in white adipose tissues were altered in diabetic GK rats in an organ-specific
manner, which was reflected in the serum levels of NEFA and TG. Changes in adipose ADMA-related enzymes might
play a part in the function of white adipose tissue.
Keywords: Protein N-arginine methyltransferase 1, Dimethylarginine dimethylaminohydrolase 1 and 2, Non-esterified
fatty acids, Triglycerides, Type 2 diabetes mellitusIntroduction
Asymmetric NG,NG-dimethylarginine (ADMA), a natur-
ally occurring inhibitor of nitric oxide synthase (NOS),
is produced by the proteolysis of intracellular proteins
that are posttranslationally modified by type I protein
N-arginine methyltransferase (PRMT) [1]. PRMT1 is a
dominant type I enzyme responsible for generating overCorrespondence: iwasaki.har@gmail.com
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reproduction in any medium, provided the orthe 85% of total N-methyltransferase activity in mamma-
lian cells [1]. Dimethylarginine dimethylaminohydrolase
1 and 2 (DDAH1/2) catalyze the hydrolysis of ADMA
into L-citrulline and dimethylamine [2]. Therefore, PRMT1
and DDAH1/2 can determine the bioavailable cellular
ADMA levels and subsequent local NO levels [3]. Human
adipocytes and white adipose tissue have been shown to
express the full enzymatic machinery required for ADMA
production and metabolism [4].
The Goto-Kakizaki (GK) rat, an inbred congenic strain
with type 2 diabetes mellitus (T2DM) without apparent
obesity [5], is not known to have any major defects in thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tokines [6]. Neither the macrophage density nor
macrophages-per-adipocyte ratio is altered in GK rats;
however, the blood flow in their white adipose tissue is
markedly increased with the considerable contribution
of the NOS/NO system [7,8].
Based upon these characteristics of GK rats, the
present study aims to explore the possible involvement
of PRMT1 and DDAH1/2 in the function of white adi-
pose tissue through the dynamics and characteristic of
these ADMA-related enzymes in T2DM.
Methods
Animals
Both 11- and 20-week-old male Wistar and GK rats were
housed with free access to water and standard rat diet
(352 kcal/100 g) and measured for body-weight. The
animal care and all experimental protocols followed the
National Institutes of Health guidelines and were approved
the local Ethics Committee. The GK rats did not show any
gross change in their body-weight or liner growth com-
pared with Wistar controls. Male GK rats as well as Wistar
rats have shown to reach sexual maturity at approximately
10–12 weeks of age, suggesting that impaired sexual mat-
uration is unlikely to occur in the GK rats.
Sample preparation
Blood samples were harvested from the tail vein of the
rats during the postprandial period. Serum non-esterified
fatty acids (NEFA) and triglycerides (TG) levels were
determined by standard enzymatic methods (Wako Pure
Chemical, Tokyo, Japan). After the rats were sacrificed,
periepididymal, visceral and subcutaneous fats and femur
muscle tissues were immediately harvested. Tissue extracts
were then prepared by the dissection and homogenization
of the tissues in ice-cold lysis buffer [25 mM HEPES,
pH 7.9, 1% NP-40, 137 mM NaCl, 1 × protease inhibitor
cocktail (Roche, Indianapolis, IN)] using a Polytron
homogenizer (Brinkman Instruments, Westbury, NY) at
4°C. The samples were centrifuged at 2000× g for 5 min at
4°C, and the resulting supernatants were then recentri-
fuged at 14000× g for 20 min at 4°C. The aliquots were
used in the following experiments.
Immunoblotting
Immunoblot experiments were performed as previously
described [9]. The tissue extracts were resolved using
3 × SDS-polyacrylamide gel electrophoresis (PAGE) buf-
fer (187.5 mM Tris–HCl, 6% SDS, 30% glycerol, 150 mM
dithiothreitol, 0.3% bromophenol blue, pH 6.8), and the
samples were boiled for 5 min at 95°C. After centrifuga-
tion at 15000 × g, the aliquots were subjected to 7.5%
SDS-PAGE. The proteins in the gel were transferred to a
nitrocellulose membrane (GE Healthcare Biosciences,Tokyo, Japan) by electroblotting. The membranes were
treated with anti-PRMT1 (1:4000, Upstate Biotechnology,
Lake Placid, NY), anti-DDAH1 (1:1000, Santa Cruz
Biotechnology, Santa Cruz, CA), anti-DDAH2 (1:2000,
Santa Cruz Biotechnology), or anti-actin antibody (1:5000,
Sigma-Aldrich, St. Louis, MO) followed by appropriate
secondary antibody conjugated to HRP (1:10000–20000,
Santa Cruz Biotechnology and GE Healthcare Biosciences).
Immunoreactive proteins were detected using the ECL
Plus system (GE Healthcare Biosciences). For the quantifi-
cation of the results, the bands were measured using the
NIH Image software (Image J version 1.2; National Insti-
tutes of Health, Bethesda, MD).
In vitro methyltransferase assay
The tissue extracts (1 mg) were subjected to immunopreci-
pitation with a monoclonal anti-PRMT1 antibody (Abcam,
Cambridge, MA) bound to protein A/G agarose (Santa
Cruz Biotechnology). In vitro methylation was achieved
by adding the immune complexes to R3 peptide (Ac-
GGRGGFGGRGGFGGRGGFG-NH2; Invitrogen, Carlsbad,
CA) and [3H]-S-adenosylmethionine (AdoMet) (148 kBq;
GE Healthcare Biosciences) in a final volume of 35 μl with
PBS for 90 min at 37°C as previously described [9]. The
reaction was terminated by adding 20 μl 3 × SDS-PAGE
buffer. The samples were heated at 95°C for 5 min,
chilled at 4°C for 5 min, and centrifuged at 15000 × g.
The supernatants were subjected to SDS-PAGE in a 5%
Tris–HCl gel, transferred to a poly(vinylidene difluoride)
membrane (Millipore, Billerica, MA), sprayed with
En3hance (PerkinElmer Life and Analytical Sciences,
Boston, MA), and exposed to Kodak BioMax MS film
(Eastman Kodak Company, Rochester, NY) with the
Transcreen LE Intensifying Screen (Eastman Kodak
Company) for 2–5 days at −80°C. Following exposure,
the membrane was washed twice with the transfer
buffer and then stained with Coomassie brilliant blue
for 5 min to detect the amount of R3 peptides trans-
ferred to the membrane. The methyltransferase activity
was quantified by measuring the signal on the exposed
blot using Image-J.
In vitro citrulline assay
DDAH activity was assessed by an L-citrulline assay adapted
from a previous report [10]. Tissue extracts (300 μg) were
incubated with urease (100 U/ml; Sigma-Aldrich) for
15 min at 37°C, and then 400 μl of ADMA (1 mM; Alexis
Biochemicals, Plymouth Metting, PA) in sodium phosphate
buffer was added to 100 μl of each sample for 45 min at
37°C. The reaction was terminated by the addition of
500 μl of 4% sulfosalicylic acid, and the samples were
mixed and centrifuged at 3000 × g for 10 min. The super-
natant (100 μl) and L-citrulline standard (3.125—100 μM;
Alexis Biochemicals) were then divided into a 96-well
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triplicate, and 100 μl of the color mixture (33% v/v of
oxime reagent with 66%v/v of antipyrine/H2SO4 reagent;
Sigma-Aldrich) was added to each well. The plate was cov-
ered with a sealing film (EXCEL Scientific, Victorville,
CA), shaken for 1 min, incubated in the dark for 110 min
at 60°C, and then cooled in an ice bath for 10 min. The ac-
tivity was then measured by spectrophotometric analysis
at 450 nm/620 nm (Immuno Mini NJ-2300, Nihon
InterMed, Tokyo, Japan).
Statistical analysis
Statistical analyses were performed using the StatView
software (SAS Institute Inc., Cary, NC). Data are pre-
sented as the mean± standard error of the mean (SEM).
The comparisons between experimental groups were per-
formed using an unpaired Student’s t test. The Pearson’s
correlation coefficient was used for correlations. A p< 0.05
was considered statistically significant.
Results
First, to examine the alteration of PRMT1 and DDAH1/2
expression and activity in the white adipose tissue of GK













































Wistar        GK
Figure 1 Relative expression and enzymatic activity of PRMT1 in the w
fat pads from 11- (A, B) and 20-week-old (C, D) Wistar (open bars) and GK r
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Ado-Met, S-adenosylmethionine.using tissue extracts in the periepididymal fat. The PRMT1
protein level of periepididymal fat decreased by 12% in
11-week-old GK rats compared to that of the age-
matched Wistar controls (p = 0.037) (Figure 1A). Con-
sistent with the alteration of PRMT1 expression, the
catalytic activity of PRMT1 in the tissue of 11-week-old
GK rats was 28% lower compared to the corresponding
control value (p=0.003) (Figure 1B). Similar results were
obtained from the adipose tissue of 20-week-old GK rats
that had 23% less PRMT1 protein (p=0.208) (Figure 1C)
accompanied by a 40% reduction in the PRMT1 activity
(p = 0.005) (Figure 1D) compared to the age-matched
Wistar controls.
The DDAH1 protein level in the tissue extracts from
the periepididymal fat of GK rats was increased by 20%
at 11 weeks of age and 84% at 20 weeks of age compared
with the age-matched controls (p= 0.046 and 0.003, re-
spectively) (Figure 2A and D). In contrast, the DDAH2
protein levels were lower in the tissue of GK rats than in
the control rats, with a 34% reduction for 11-week-old
and a 30% reduction for 20-week-old rats compared to
the corresponding control values (p< 0.001 and p=0.024,
respectively) (Figure 2B and E). The catalytic activities of
adipose DDAH in GK rats were 2.5-fold and 3.6-foldCBB staining
[3H]-AdoMet
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Figure 2 Relative expression and enzymatic activity of DDAHs in the white adipose tissue of GK rats. The extracts of the periepididymal
fat pads from 11- (A–C) and 20-week-old (D–F) Wistar (open bars) and GK rats (closed bars) were analyzed for DDAH1 and DDAH2 expression, and
total DDAH activity. Representative results are shown in the upper panels. Each bar in the graph represents the mean± SEM (n = 5–10). The
percentile represents the relative level of expression or activity to that of the age-matched Wistar controls. *p< 0.05, **p< 0.01 vs. the controls.
IB, immunoblotting.
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20-week-old rats, respectively (p< 0.001 and p< 0.001,
respectively) (Figure 2C and F).
To examine whether the above-mentioned modifica-
tion applies to the other localized adipose tissues or a
different organ, the expression and activities of PRMT1
and DDAH1/2 were evaluated in visceral and subcutane-
ous fats and skeletal muscle tissue (Table 1). The patterns
of modification in the extracts of visceral and subcutane-
ous fats from 11-week-old GK rats were nearly identical
with those of periepididymal fat, showing significant
decreases in PRMT1 and DDAH2 expression and PRMT1
activity and increases in DDAH1 expression and DDAH
activity compared to the age-matched Wistar controls.
However, the characteristics of ADMA-related enzymes in
the skeletal muscle tissues of 11- and 20-week-old GK rats
were distinct from those of the white adipose tissues,
suggesting that white adipose tissues of GK rats might
express and regulate for ADMA-related enzymes in an
organ-specific manner.Characteristics of Wistar control and GK diabetic rats at
11 and 20 weeks of age are shown in Table 2. Both 11- and
20-week-old GK rats were equivalent to the age-matched
Wistar controls in body-weight (p=0.408 and p=0.496,
respectively). During the postprandial state, the serum
levels of NEFA were lower in 11- and 20-week-old GK rats
compared to the age-matched Wistar controls (p= 0.027
and p=0.002, respectively). GK rats also exhibited lower
TG levels compared to the corresponding control values
(p< 0.001 for 11-week-old and p< 0.001 for 20-week-old).
For all 11-week-old subjects, a significant positive linear cor-
relation was observed between PRMT1 activity and serum
NEFA or TG level (p=0.025 and p=0.017, respectively)
(Figure 3A and B). A negative correlation was also observed
between DDAH activity and the serum NEFA or TG level
(p=0.001 and p< 0.001, respectively) (Figure 3C and D).
Discussion
The present study demonstrated that the white adipose
tissue of diabetic GK rats exhibited a high level of DDAH1
Table 1 Expression and activities of ADMA-related enzymes in the white adipose and skeletal muscle tissues of control
Wistar and diabetic GK rats
PRMT1 expression PRMT1 activity
Wistar GK Wistar GK
Visceral fat 100 ± 2 75.7 ± 6.1** 100 ± 3 41.9 ± 6.4**
Subcutaneous fat 100 ± 4 79.0 ± 3.3** 100 ± 5 73.4 ± 6.4**
Skeletal muscle (11 weeks of age) 100 ± 4 109 ± 9 100 ± 4 102 ± 3
Skeletal muscle (20 weeks of age) 100 ± 2 117 ± 2 100 ± 3 125 ± 4**
DDAH1 expression DDAH2 expression DDAH activity
Wistar GK Wistar GK Wistar GK
Visceral fat 100 ± 9 138 ± 9 100 ± 7 68.7 ± 6.5** 100 ± 7 259 ± 19**
Subcutaneous fat 100 ± 10 139 ± 5* 100 ± 5 73.5 ± 3.3* 100 ± 8 245 ± 33*
Skeletal muscle (11 weeks of age) 100 ± 10 90.8 ± 2.3 100 ± 21 136 ± 11 100 ± 9 91.4 ± 9.3
Skeletal muscle (20 weeks of age) 100 ± 5 96.0 ± 5.4 100 ± 5 144 ± 7** 100 ± 5 109 ± 6
Values represent the mean ± SEM of five to ten rats in each group and are expressed as the percentile for the relative level of expression or activity to that of the
age-matched Wistar controls. *p< 0.05, **p< 0.01 vs. the controls.
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pared to controls, whereas PRMT1 expression and activity
were reduced in the tissue. The dynamics of adipose
ADMA-related enzymes is apparently distinct from those
of skeletal muscle tissues, indicating that this modification
is likely to occur in an organ-specific manner. The adipose
ADMA-related enzyme activities reflected serum levels of
lipid biomarkers such as NEFA and TG. These data sug-
gest that the adipose ADMA metabolism may be flexibly
modulated in metabolic disorders, and may be involved in
the function of white adipose tissue.
It has been reported that liver and pancreas lysates
from GK rats displayed low PRMT1 activities and this
may be associated with defective hepatic insulin signal-
ing, excessive gluconeogenesis in the liver, and inappro-
priate glucose-stimulated insulin secretion in GK rats
[9]. The present study demonstrates that the white adi-
pose tissue of GK rats had lower PRMT1 activity relative
to control Wistar rats. Because the tissue lysates of GK
rats exhibited a low degree of PRMT1 expression, the
decreased activity may be partly responsible for the low
protein level. The present study also revealed that GK
rats exhibit an increase in adipose DDAH1 expression,
whereas adipose DDAH2 expression was diminished com-
pared to the controls. The catalytic activity of adipose
DDAH in GK rats was greater than that of the controls.Table 2 Characteristics of Wistar control and GK diabetic
rats at 11 and 20 weeks of age
11 weeks of age 20 weeks of age
Wistar GK Wistar GK
Body-weight (g) 250 ± 4 242 ± 5 329 ± 5 323 ± 6
Non-esterified
fatty acids (mEq/l)
0.38 ± 0.02 0.26 ± 0.02* 0.43 ± 0.01 0.22 ± 0.03**
Triglycerides (mg/dl) 140 ± 10 76± 6** 159 ± 14 88 ± 7**
Values represent the mean ± SEM of five to ten rats in each group. *p< 0.05,
**p< 0.01 vs. the age-matched Wistar control rats.Adipose DDAH1 expression is concomitant with DDAH
activity and is, therefore consistent with the previous
report on human cultured adipocytes and white adipose
tissue [4]; DDAH1 may predominate in this tissue of
the subjects.
The mechanism(s) for the modification of PRMT1 and
DDAH1/2 expression in the adipose tissue of GK rats
remains to be determined. Interestingly, an opposite pat-
tern of the expression of the DDAH subtypes is proposed
in the kidneys of streptozotocin-induced diabetic rats.
DDAH1 expression is decreased but PRMT1 and DDAH2
expression is increased under angiotensin II (AngII) type 1
receptor (AT1-R) activation [11]. Furthermore, AT1-R acti-
vation in the rat retina also leads to high PRMT1 and low
DDAH1 expression, which is implicated in the progression
of diabetic retinopathy [12]. An increase in circulating
NEFA levels by lipid/heparin infusion mimics the abnor-
mal lipid profile in patients with insulin resistance and
causes endothelial dysfunction via an AT1-R-dependent
reduction of NO synthesis [13]. In agreement with these
reports, incubation of differentiated 3T3-L1 adipocytes
with either AngII or saturated fatty acid (palmitic acid)
results in increased PRMT1 expression and decreased
DDAH1 expression (Iwasaki, unpublished observation).
Taken together, NEFA could suppress the production of
bioavailable adipose NO subsequent to the modulation
of local ADMA-related enzymes through the AT1-R-
dependent pathway, which may partly account for the
relationships between lipid biomarker levels and adipose
PRMT1 or DDAH activity.
The IC50 of ADMA on NOS is approximately 10 μM
and the intracellular ADMA levels are normally well above
this IC50 level due to intracellular accumulation via the
cationic amino acid transporter [2,3]. A 50% increase in
cellular DDAH activity by DDAH1 overexpression results
in a 22% increase in intracellular NO production [14],
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Figure 3 Correlation analysis of the relationships between the activities of ADMA-related enzymes and lipid biomarker levels. The
values of the parameters are depicted for 11-week-old Wistar (open circles) and GK rats (closed circles) in Figure 1B, Figure 2C and Table 2. The lines
show linear regressions for the parameters indicated in each graph. The Pearson’s correlation coefficients (R2) and p values for each correlation are
also indicated in the graph.
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local NO production. GK rats have increased blood flow
in white adipose tissue [7,8]. Although a major propor-
tion of the postprandial enhancement appears to be
under β-adrenergic control, the NOS/NO system contri-
butes considerably to hyperperfusion in this tissue [7,8].
Taken together, the modification of adipose ADMA-
related enzyme activities may be implicated in the
enhanced white adipose tissue blood flow in GK rats
and possibly associated with the machinery for adipose
functions.
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